Skip to Content

Notice

Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the agency's Dockets Management Branch.

ADDRESSES:

Submit written requests for copies of summaries of safety and effectiveness to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summary of safety and effectiveness.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Thinh Nguyen, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-2186.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

I. Background

In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule to revise §§ 814.44(d) and 814.45(d) (21 CFR 814.44(d) and 814.45(d)) to discontinue publication of individual PMA approvals and denials in the Federal Register. Instead, revised §§ 814.44(d) and 814.45(d) state that FDA will notify the public of PMA approvals and denials by posting them on FDA’s Intranet home page at http://www.fda.gov;​ by placing the summaries of safety and effectiveness on the Internet and in FDA's Dockets Management Branch; and by publishing in the Federal Register after each quarter a list of available safety and effectiveness summaries of approved PMAs and denials announced in that quarter.

FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register, and FDA believes that the Internet is accessible to more people than the Federal Register.

In accordance with section 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.

The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet in accordance with the procedure explained previously from January 1, 2001, through March 31, 2001. There were no denial actions during this period. The list provides the Start Printed Page 35646manufacturer's name, the product's generic name or the trade name, and the approval date.

Table 1.—List of Safety and Effectiveness Summaries for Approved PMAs Made Available January 1, 2001, through March 31, 2001

PMA No./Docket No.ApplicantTrade NameApproval Date
P970043/00M-1592Autonomous Technologies Corp.LADARVision® Excimer Laser SystemNovember 2, 1998
P970025/01M-0072DiaSorin, Inc.PRO-TRAC IITM Tacrolimus ELISA KitApril 27, 1999
P970049/01M-0043Laser Institute of the RockiesDishler Excimer Laser SystemDecember 16, 1999
P970053(S2)/00M-0014Nidek Technologies, Inc.EC 5000 Excimer Laser SystemApril 14, 2000
P990074/00M-0012McGhan Medical Corp.RTV Saline-Filled Breast ImplantsMay 10, 2000
P990075/00M-0011Mentor Corp.Saline-Filled and Spectrum® Mammary ProsthesesMay 10, 2000
P000009/01M-0042Biotronik, Inc.Phylax AV Implantable Cardioveter Defibrillator with Program SoftwareSeptember 29, 2000
P000011/00M-0055Biocompatibilities Cardiovascular, Inc.Biodiv YsioTM AS PC Coated Stent and Delivery SystemSeptember 29, 2000
P000022/01M-0039Medtronic AVE, Inc.AVE BeStentTM 2 with Discrete ­TechnologyTM Coronary ­Stent ­Delivery SystemOctober 16, 2000
P930016(S10)/00M-0015VISX, Inc.STAR S2 and S3 Excimer ­Laser ­SystemOctober 18, 2000
P910023(S47)/01M-0041St. Jude Medical, Inc.PhotonTM DR Implantable Cardioverter Defibrillator (ICD)October 27, 2000
P000027/00M-1683Roche Diagnostics Corp.Elecsys Free ­Immunoassay ­Calset/CalcheckDecember 12, 2000
P970013/00M-0013St. Jude Medical, Inc.MicronyTM SR+ Model 2425TDecember 21, 2000
P980020/00M-1684Q Care International, LLCQ 103 Needle Management SystemsDecember 21, 2000
P950021(S2)/01M-0038Bayer Corp.ACS: 180 and Advia ­Centaur ­PSA ­AssaysDecember 22, 2000
H000001/01M-0062JOMED ABJOMED JOSTENT® Coronary Stent GraftJanuary 10, 2001
P990085/01M-0149VISTAKON (Division of ­Johnson ­& ­Johnson ­Vision Care, Inc.)VISTAKON Soft Contact Lenses for Extended WearFebruary 16, 2001
H990013/01M-0201Ortec International, Inc.Composite Cultured Skin (CCS)February 21, 2001

II. Electronic Access

Persons with access to the Internet may obtain the documents at http://www.fda.gov/​cdrh/​pmapage.html.

Start Signature

Dated: June 21, 2001.

Linda S. Kahan,

Deputy Director for Regulations Policy, Center for Devices and Radiological Health.

End Signature End Supplemental Information

[FR Doc. 01-16918 Filed 7-5-01; 8:45 am]

BILLING CODE 4160-01-S